Alambic Investment Management, L.P. - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 348 filers reported holding NEKTAR THERAPEUTICS in Q4 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
Alambic Investment Management, L.P. ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2018$633,000
+6.0%
10,381
-15.0%
0.50%
+205.5%
Q2 2018$597,000
-86.2%
12,216
-70.0%
0.16%
-72.8%
Q1 2018$4,325,000
+145.2%
40,700
+37.8%
0.60%
+184.0%
Q4 2017$1,764,000
+490.0%
29,540
+93.1%
0.21%
+488.9%
Q2 2017$299,000
-57.5%
15,300
-49.0%
0.04%
-58.6%
Q1 2017$704,000
+200.9%
30,000
+57.1%
0.09%
+107.1%
Q4 2016$234,00019,1000.04%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2018
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders